Sondel P M, Bach F H
J Exp Med. 1975 Dec 1;142(6):1339-48. doi: 10.1084/jem.142.6.1339.
The specificity of antigen recognition by in vitro sensitized human cytotoxic T lymphocytes (CTLs) has been studied using a sensitive cell-mediated lympholysis (CML) assay. Frequently, high levels of cytotoxicity are observed on third-party targets unrelated to sensitizing or responding cells; however, no cytotoxicity differing significantly from zero has been observed on targets autologous to the responding CTLs. This "cross-killing" of third-party target cells has been observed when stimulating and third-party cells bear no cross-reacting serologically defined (SD) antigens, thought to be the target antigens recognized by CTLs. CML-blocking studies, using unlabeled normal human lymphocytes to inhibit 51Cr release from radiolabeled target cells, have shown that cross-killing, even in the absence of shared SD determinants, results from CTLs recognizing antigens shared by the third-party targets and the initial stimulating population. Furthermore, these antigens have been mapped to the major histocompatibility complex (MHC). The ability of human CTLs to specifically recognize MHC-controlled antigens not detected serologically suggests that SD antigens may be recognized differently by alloantisera and CTLs, or that MHC antigens other than SD may be the targets of CTLs in CML.
利用一种灵敏的细胞介导淋巴细胞溶解(CML)试验,对体外致敏的人细胞毒性T淋巴细胞(CTL)识别抗原的特异性进行了研究。通常,在与致敏细胞或反应细胞无关的第三方靶细胞上可观察到高水平的细胞毒性;然而,在与反应性CTL自体的靶细胞上未观察到明显不同于零的细胞毒性。当刺激细胞和第三方细胞不携带交叉反应的血清学定义(SD)抗原(被认为是CTL识别的靶抗原)时,就会观察到第三方靶细胞的这种“交叉杀伤”现象。使用未标记的正常人淋巴细胞抑制放射性标记靶细胞释放51Cr的CML阻断研究表明,即使在没有共享SD决定簇的情况下,交叉杀伤也是由于CTL识别第三方靶细胞和初始刺激群体共有的抗原所致。此外,这些抗原已被定位到主要组织相容性复合体(MHC)。人CTL特异性识别血清学未检测到的MHC控制抗原的能力表明,SD抗原可能被同种抗血清和CTL以不同方式识别,或者在CML中,除SD之外的MHC抗原可能是CTL的靶标。